Publications by authors named "Rive Sarfstein"

Claim this Profile
R
RETRACTED: Sarfstein et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells. 2010, , 233-261.
Rive Sarfstein, Antonino Belfiore, Haim Werner

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP.
Karthik Nagaraj, Rive Sarfstein, Zvi Laron, Haim Werner

Cells· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action.
Rive Sarfstein, Karthik Nagaraj, Shivang Parikh, Carmit Levy, Zvi Laron

Cells· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease.
Laris Achlaug, Lina Somri-Gannam, Shilhav Meisel-Sharon, Rive Sarfstein, Manisha Dixit

Front Endocrinol (Lausanne)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression.
Danielle Yaron-Saminsky, Karthik Nagaraj, Rive Sarfstein, Zvi Laron, Metsada Pasmanik-Chor

Int J Mol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.
Rand Shibel, Rive Sarfstein, Karthik Nagaraj, Lena Lapkina-Gendler, Zvi Laron

Cells· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.
Rive Sarfstein, Adva Yeheskel, Tali Sinai-Livne, Metsada Pasmanik-Chor, Haim Werner

Front Endocrinol (Lausanne)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to 'Identification of nephronectin as a new target for IGF1 action' [Eur J Canc 141 (2020) Pages 115-127].
Rive Sarfstein, Lena Lapkina-Gendler, Karthik Nagaraj, Zvi Laron, Haim Werner

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer.
Haim Werner, Rive Sarfstein, Zvi Laron

Biomolecules· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of nephronectin as a new target for IGF1 action.
Rive Sarfstein, Lena Lapkina-Gendler, Karthik Nagaraj, Zvi Laron, Haim Werner

Eur J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.
Haim Werner, Rive Sarfstein, Karthik Nagaraj, Zvi Laron

Cells· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressor p53 regulates insulin receptor () gene expression via direct binding to the promoter.
Rive Sarfstein, Haim Werner

Oncotarget· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy.
Haim Werner, Rive Sarfstein, Ilan Bruchim

Expert Opin Investig Drugs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
Rive Sarfstein, Karthik Nagaraj, Derek LeRoith, Haim Werner

Cells· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer.
Laris Achlaug, Rive Sarfstein, Karthik Nagaraj, Lena Lapkina-Gendler, Ilan Bruchim

Oncotarget· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways.
Haim Werner, Lena Lapkina-Gendler, Laris Achlaug, Karthik Nagaraj, Lina Somri, Rive Sarfstein

Cells· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.
Lina Somri, Rive Sarfstein, Lena Lapkina-Gendler, Karthik Nagaraj, Zvi Laron

Growth Horm IGF Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action.
Daniel Aizen, Metsada Pasmanik-Chor, Rive Sarfstein, Zvi Laron, Ilan Bruchim

Front Endocrinol (Lausanne)· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.
Karthik Nagaraj, Lena Lapkina-Gendler, Rive Sarfstein, David Gurwitz, Metsada Pasmanik-Chor

Proc Natl Acad Sci U S A· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear insulin-like growth factor-1 receptor (IGF1R) displays proliferative and regulatory activities in non-malignant cells.
Ravid Solomon-Zemler, Rive Sarfstein, Haim Werner

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways.
Haim Werner, Rive Sarfstein, Derek LeRoith, Ilan Bruchim

Front Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of signaling pathways associated with cancer protection in Laron syndrome.
Lena Lapkina-Gendler, Itai Rotem, Metsada Pasmanik-Chor, David Gurwitz, Rive Sarfstein

Endocr Relat Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proliferative and signaling activities of insulin analogues in endometrial cancer cells.
Daniel Aizen, Rive Sarfstein, Ilan Bruchim, Doron Weinstein, Zvi Laron

Mol Cell Endocrinol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin analogues display atypical differentiative activities in skin keratinocytes.
Ravid Solomon Zemler, Galina Weingarten, Rive Sarfstein, Zvi Laron, Haim Werner

Arch Physiol Biochem· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer.
Ilan Bruchim, Rive Sarfstein, Ari Reiss, Eliezer Flescher, Haim Werner

Cancer Lett· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis